Chimerism and immunological tolerance in solid organ transplantation

Area of Science:

• Immunology
• Transplantation Biology
• Cellular Biology

Background:

• Solid organ transplantation necessitates long-term immunosuppression due to host immune responses against the graft.
• Chimerism, the presence of donor-derived cells within the recipient, is a natural consequence of organ transplantation.
• Achieving donor-specific immunological tolerance is crucial for long-term graft survival and reducing immunosuppressive drug toxicity.

Purpose of the Study:

• To review the historical development, clinical outcomes, and scientific principles of chimerism-based tolerance in solid organ transplantation.
• To explore the potential of deliberately inducing stable mixed bone marrow chimerism for achieving donor-specific tolerance.
• To discuss the role of naturally occurring feto-maternal microchimerism in immune tolerance relevant to organ transplantation.

Main Methods:

• Review of existing literature on chimerism and transplantation tolerance.
• Analysis of historical data and clinical case series.
• Examination of the biological mechanisms underlying chimerism-induced immune tolerance.

Main Results:

• Stable mixed bone marrow chimerism has been established in animal models and shows promise in clinical settings.
• Current conditioning regimens for inducing chimerism are associated with significant toxicity, limiting widespread clinical application.
• Feto-maternal microchimerism demonstrates the capacity of naturally occurring chimerism to induce immune tolerance.

Conclusions:

• Deliberate induction of stable chimerism offers a promising strategy to achieve donor-specific tolerance in organ transplant recipients.
• Overcoming the toxicity of conditioning regimens is essential for the clinical translation of chimerism-based tolerance strategies.
• Understanding microchimerism provides insights into natural mechanisms of immune tolerance that could be leveraged in transplantation.